Source: ERS Course 2016



Rating:

Share or cite this content

Citations should be made in the following way:
G. Verleden (Leuven, Belgium). CLAD or BOS? : classification and pathogenesis. ERS Course 2016

Member's Comments

No comment yet.

Related content which might interest you: The pathogenesis of IPF: what is the latest paradigm? Source: International Congress 2019 – New Horizons in The Treatment of Pulmonary Fibrosis Year: 2019 BOS sub-phenotyping: beyond lung function Source: School Course 2012 - Lung Transplantation Year: 2012 Bronchiolitis obliterans syndrome: still a valid terminology to reflect chronic rejection? Source: Annual Congress 2011 - Novelties in lung transplantation Year: 2011 Can we predict development of bronchiolitis obliterans syndrome (BOS) according to parameters of oxidative stress in lung transplant recipients? Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007 Interstitial pneumonia with autoimmune features: a new classification still on the move Source: Eur Respir Rev, 27 (148) 180047; 10.1183/16000617.0047-2018 Year: 2018 Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal? Source: Eur Respir J 2005; 25: 221-224 Year: 2005 Bronchiolitis obliterans syndrome after single lung transplantation: impact of time to onset on functional pattern and survival Source: Eur Respir J 2002; 20: Suppl. 38, 563s Year: 2002 COPD: an autoimmune disease? Source: Eur Respir J 2011; 38: 484 Year: 2011 The obstacle race of post-infectious bronchiolitis obliterans (PIBO): Prognostic factor analysis Source: International Congress 2016 – Paediatric respiratory infection Year: 2016 Azithromycin and bronchiolitis obliterans syndrome after lung transplantation: is prevention better than cure? Source: Eur Respir J 2011; 37: 10-12 Year: 2011 Pulmonary function and clinical outcome of patients with post-infectious bronchiolitis obliterans (BO) Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007 Chronic lung allograft rejection: prevalence, pathology, risk factors and pathophysiology Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=1 Year: 2004 Lung abnormalities in marfan syndrome: a pathogenetic model of early-onset emphysema? Source: Annual Congress 2009 - Respiratory physiology Year: 2009 Incidence and risk factors for bronchiolitis obliterans syndrome stage 0p after lung transplantation Source: International Congress 2018 – Moving lung transplantation forward Year: 2018 Early diagnosis of bronchiolitis obliterans syndrome diagnosis after lung transplantation using functional respiratory imaging (FRI) Source: International Congress 2016 – Long-term outcomes of lung transplantation Year: 2016 Interstitial pneumonia with autoimmune features: applying novel diagnostic criteria to an existing patient cohort. Source: International Congress 2017 – Novel and old entities Year: 2017 Introduction: new therapeutic approaches to bronchiolitis obliterans Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation Year: 2005 Bronchiolitis obliterans (BO) in mice lung: a simple model by nasal-drop Source: Eur Respir J 2005; 26: Suppl. 49, 732s Year: 2005 A new paradigm for classification of disease severity and progression of COPD Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012 A new biomarker for chronic lung allograft dysfunction Source: International Congress 2014 – Chronic lung allograft dysfunction: mechanisms, predictors and phenotypes Year: 2014